OTT Releases in July 2024: ‘Sarfira’, ‘Kakuda’ ’36 Days’, ‘Pill’ on Netflix, Prime Video, ZEE5 etc

sarfira movie release

Yet another remake of Tamil hit movies starring Akshay Kumar is scheduled for Friday’s release.

Here’s a roundup of the entertainment releases on various OTT platforms for the second week of July 2024 on popular OTT platforms like Amazon Prime Video, Netflix, ZEE5, Disney+Hotstar, etc.

“Sarfira” (Theatres):

This Akshay Kumar starrer is a remake of Suriya’s Tamil hit film “Soorarai Pottru” (2020). It is about the inspiring story of G. R. Gopinath, who aimed to make affordable airlines for people with low income. The film also features Paresh Rawal and Radhika Madan.

Aha:

“Harom Hara” (Telugu film) – July 11

Amazon Prime Video:

“Maidaan” (Hindi film – Telugu dub) – July 9

Disney Plus Hotstar:

“Commander Karan Saxena” (Hindi web series) – July 9
“Agnisakshi” (Telugu web series) – July 12

See Also:  Ballerini's Snowy Bliss: Bikini Glow with Stokes – Embracing the Little Life

“Showtime” Season 1- Part 2 (Hindi web series) – July 12

The exhilarating drama continues, shedding light on power struggles in the entertainment world. Emraan Hashmi, Mahima Makwana, Mouni Roy, Rajeev Khandelwal, Shriya Saran, and others reprise their roles from the first season.

Netflix:

“Blame the Game” is A comedy flick where a young man’s meeting with his girlfriend’s parents takes an unexpected twist during a game night. The movie stars Dennis Mojen, Janina Uhse, and Anna Maria Mühe.

“Maharaja” (Tamil film – Telugu dub) – July 12

Sony LIV:

“36 Days” (Hindi web series) – July 12

ZEE5:

“Kakuda” (Hindi film) – July 12

Jio Cinema:

“Pill” (Hindi web series – Telugu dub) – July 12

Starring Riteish Deshmukh, this medical series focuses on a doctor’s battle against a powerful pharma company, Forever Cure.

See Also:  Photos: Asin, Shriya Saran, Kajal Agarwal dazzle at the South Indian International Movie Awards

Dr. Prakash, along with three other whistle-blowers, expose the truth behind a harmful pill manufactured by a billion-dollar pharma company.

camelia
About Camelia Bhattacharyya 218 Articles
Camelia is an intern for PanAsiaBiz studying at the Amity University, Kolkata [B. Tech (biotechnology)]. She is fond of writing on Science, Health, and Biotechnology topics.

Be the first to comment

Leave a Reply

Your email address will not be published.